Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors

Related articles

1. CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection

   This article has 11 authors:

   1. Kyoto Matsudo
   2. Kazuki Takada
   3. Asato Hashinokuchi
   4. Taichi Nagano
   5. Fumihiko Kinoshita
   6. Takaki Akamine
   7. Mikihiro Kohno
   8. Tomoyoshi Takenaka
   9. Mototsugu Shimokawa
   10. Yoshinao Oda
   11. Tomoharu Yoshizumi

2. Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer

   This article has 18 authors:

   1. Natalie J. Miller
   2. Christina S. Baik
   3. Joel W. Neal
   4. Fangdi Sun
   5. Rafael Santana-Davila
   6. Sylvia Lee
   7. Keith D. Eaton
   8. Renato G. Martins
   9. Cristina Rodriguez
   10. Heather A. Wakelee
   11. Sukhmani K. Padda
   12. Eric Q. Konnick
   13. Alex Camai
   14. Tatyana Pisarenko
   15. Viswam S. Nair
   16. A. McGarry Houghton
   17. Shin-Heng Chiou
   18. Diane Tseng

3. The Prognostic and Predictive Role of ATM Expression in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Pembrolizumab Monotherapy or Combination with Chemotherapy

   This article has 8 authors:

   1. Jamshid Hamdard
   2. Harun Muğlu
   3. Ahmet Bilici
   4. Elif Kuzucular
   5. Özgür Açıkgöz
   6. Ömer Fatih Ölmez
   7. Oktay Olmuşçelik
   8. Özcan Yıldız